Back to Industry News
Medtech
SheMed Secures $50 Million Funding for UK Weight-Loss Expansion
Summary generated with AI, editor-reviewed
Heartspace News Desk
•Source: Reuters
TL;DR
London's SheMed, a weight-loss telehealth company for women, has raised $50 million in Series A funding, giving them a $1 billion valuation. With over 60,000 members, SheMed plans to use the funds for UK expansion, research, and to improve personalized care accessibility.
Stay updated on stories like this
Key takeaways
- SheMed, a London-based telehealth startup specializing in weight-loss programs for women, has secured $50 million in Series A funding, achieving a valuation of $1 billion
- The company offers personalized plans integrating medications like Wegovy and Mounjaro with health screenings and continuous support for its members
- This funding round follows substantial growth, with SheMed enrolling over 60,000 members as demand for these medications increases throughout the United Kingdom
SheMed, a London-based telehealth startup specializing in weight-loss programs for women, has secured $50 million in Series A funding, achieving a valuation of $1 billion. The company offers personalized plans integrating medications like Wegovy and Mounjaro with health screenings and continuous support for its members.
This funding round follows substantial growth, with SheMed enrolling over 60,000 members as demand for these medications increases throughout the United Kingdom. SheMed intends to allocate the capital to fuel its expansion across the UK, support ongoing research initiatives, and enhance accessibility to personalized care for women.
Related Topics
SheMedfundingweight lossWegovyMounjaroUK expansionmedtech
Never miss stories like this
Verified mention available
Free to claim
Is this your company?
Set up real-time alerts and keep your Heartspace News coverage accurate. Verified teams can update profiles, request corrections, and collaborate on future stories.
Set up alerts Takes under 1 minute • Verified manually